Progressive ratio, i.e. food-seeking constrained by escalating effort schedule. The last successfully completed ratio or shock intensity endured before timeout. Animals are food restricted to 85% of initial body weight, trained to lever-press for food pellets (45 mg) until stable response rates were reached, then tested either on the progressive ratio (PR) task with progressively increasing effort requirements (lever-presses required per pellet) or progressively increasing punishment (i.e., a foot-shock of increasing intensity presented 1 s after food pellet delivery, whose magnitude increases ~25% every 3 trials). In the PR task, rats time out if 2 min passed without a lever press. In the punishment task, a timeout is defined by three consecutive trials with >30 s passing without a lever press. For both tasks, the break point is the last successfully completed ratio or shock intensity endured before timeout.
Tags: Behavior · Motivation
Project: u01_tom_jhou
1 loci · 1 genes with independent associations · 1 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | 10 | 62271668 | 63667097 | 1 | 1 | 1.28e-08 | 5.35e-01 | 4.48e-09 | Eral1 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.24 |
Adipose | alternative TSS | 0 | 0 | 1.1 |
Adipose | gene expression | 1 | 0 | 1.11 |
Adipose | isoform ratio | 0 | 0 | 1.17 |
Adipose | intron excision ratio | 0 | 0 | 1.19 |
Adipose | mRNA stability | 0 | 0 | 1.14 |
BLA | alternative polyA | 0 | 0 | 1.25 |
BLA | alternative TSS | 0 | 0 | 1.12 |
BLA | gene expression | 0 | 0 | 1.18 |
BLA | isoform ratio | 0 | 0 | 1.14 |
BLA | intron excision ratio | 0 | 0 | 1.21 |
BLA | mRNA stability | 0 | 0 | 1.1 |
Brain | alternative polyA | 0 | 0 | 1.16 |
Brain | alternative TSS | 0 | 0 | 1.27 |
Brain | gene expression | 0 | 0 | 1.14 |
Brain | isoform ratio | 0 | 0 | 1.15 |
Brain | intron excision ratio | 0 | 0 | 1.19 |
Brain | mRNA stability | 0 | 0 | 1.1 |
Eye | alternative polyA | 0 | 0 | 0.86 |
Eye | alternative TSS | 0 | 0 | 0.99 |
Eye | gene expression | 0 | 0 | 1.24 |
Eye | isoform ratio | 0 | 0 | 1.15 |
Eye | intron excision ratio | 0 | 0 | 1.19 |
Eye | mRNA stability | 0 | 0 | 0.93 |
IL | alternative polyA | 0 | 0 | 1.16 |
IL | alternative TSS | 0 | 0 | 1.28 |
IL | gene expression | 0 | 0 | 1.19 |
IL | isoform ratio | 0 | 0 | 1.18 |
IL | intron excision ratio | 0 | 0 | 1.24 |
IL | mRNA stability | 0 | 0 | 1.11 |
LHb | alternative polyA | 0 | 0 | 1.39 |
LHb | alternative TSS | 0 | 0 | 1.11 |
LHb | gene expression | 0 | 0 | 1.21 |
LHb | isoform ratio | 0 | 0 | 1.24 |
LHb | intron excision ratio | 0 | 0 | 1.38 |
LHb | mRNA stability | 0 | 0 | 1.1 |
Liver | alternative polyA | 0 | 0 | 1.33 |
Liver | alternative TSS | 0 | 0 | 1.18 |
Liver | gene expression | 0 | 0 | 1.14 |
Liver | isoform ratio | 0 | 0 | 1.24 |
Liver | intron excision ratio | 0 | 0 | 1.15 |
Liver | mRNA stability | 0 | 0 | 1.09 |
NAcc | alternative polyA | 0 | 0 | 1.19 |
NAcc | alternative TSS | 0 | 0 | 1.13 |
NAcc | gene expression | 0 | 0 | 1.14 |
NAcc | isoform ratio | 0 | 0 | 1.11 |
NAcc | intron excision ratio | 0 | 0 | 1.19 |
NAcc | mRNA stability | 0 | 0 | 1.12 |
OFC | alternative polyA | 0 | 0 | 1.06 |
OFC | alternative TSS | 0 | 0 | 1.43 |
OFC | gene expression | 0 | 0 | 1.18 |
OFC | isoform ratio | 0 | 0 | 1.14 |
OFC | intron excision ratio | 0 | 0 | 1.37 |
OFC | mRNA stability | 0 | 0 | 1.13 |
PL | alternative polyA | 0 | 0 | 1.17 |
PL | alternative TSS | 0 | 0 | 1.06 |
PL | gene expression | 0 | 0 | 1.16 |
PL | isoform ratio | 0 | 0 | 1.13 |
PL | intron excision ratio | 0 | 0 | 1.26 |
PL | mRNA stability | 0 | 0 | 1.06 |